CAHC President Joel White published an op-ed in the International Business Times titled, “Doubling Down On Drug Price Controls Could Hurt Patients.”
The article, written after the release of the 10 drugs that will be subject to government price controls put in place by the Inflation Reduction Act, examines the future of prescription drugs. How will research and development of new drugs be impacted? Will patients have access to the drugs they need?